West Pharmaceutical Services Return on Investment 2010-2024 | WST

Current and historical return on investment (ROI) values for West Pharmaceutical Services (WST) over the last 10 years.
West Pharmaceutical Services ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2024-12-31 $0.57B $2.89B 20.28%
2024-09-30 $0.57B $2.96B 20.19%
2024-06-30 $0.59B $2.65B 20.64%
2024-03-31 $0.64B $2.75B 22.06%
2023-12-31 $0.68B $2.95B 22.71%
2023-09-30 $0.65B $3.02B 21.78%
2023-06-30 $0.65B $2.95B 22.74%
2023-03-31 $0.70B $2.98B 25.00%
2022-12-31 $0.73B $2.89B 27.34%
2022-09-30 $0.79B $2.68B 30.34%
2022-06-30 $0.78B $2.63B 30.94%
2022-03-31 $0.77B $2.54B 31.35%
2021-12-31 $0.75B $2.54B 32.27%
2021-09-30 $0.68B $2.41B 30.80%
2021-06-30 $0.60B $2.28B 28.52%
2021-03-31 $0.50B $2.08B 24.69%
2020-12-31 $0.41B $2.11B 21.19%
2020-09-30 $0.37B $1.97B 19.93%
2020-06-30 $0.34B $1.86B 18.94%
2020-03-31 $0.31B $1.75B 18.21%
2019-12-31 $0.30B $1.83B 17.69%
2019-09-30 $0.29B $1.68B 17.59%
2019-06-30 $0.28B $1.64B 17.59%
2019-03-31 $0.26B $1.57B 16.69%
2018-12-31 $0.24B $1.59B 15.68%
2018-09-30 $0.23B $1.55B 15.58%
2018-06-30 $0.24B $1.48B 15.81%
2018-03-31 $0.22B $1.50B 14.70%
2017-12-31 $0.23B $1.48B 15.61%
2017-09-30 $0.22B $1.51B 15.48%
2017-06-30 $0.21B $1.44B 15.01%
2017-03-31 $0.23B $1.36B 16.69%
2016-12-31 $0.20B $1.34B 14.56%
2016-09-30 $0.19B $1.37B 14.20%
2016-06-30 $0.13B $1.34B 10.31%
2016-03-31 $0.11B $1.30B 8.79%
2015-12-31 $0.13B $1.25B 10.50%
2015-09-30 $0.13B $1.23B 10.48%
2015-06-30 $0.18B $1.22B 14.24%
2015-03-31 $0.19B $1.17B 15.11%
2014-12-31 $0.18B $1.27B 13.98%
2014-09-30 $0.17B $1.29B 13.33%
2014-06-30 $0.17B $1.33B 13.20%
2014-03-31 $0.16B $1.33B 12.72%
2013-12-31 $0.16B $1.28B 13.45%
2013-09-30 $0.16B $1.22B 13.51%
2013-06-30 $0.14B $1.18B 12.69%
2013-03-31 $0.14B $1.17B 12.64%
2012-12-31 $0.14B $1.11B 13.10%
2012-09-30 $0.13B $1.08B 13.10%
2012-06-30 $0.13B $0.98B 13.32%
2012-03-31 $0.12B $0.99B 12.23%
2011-12-31 $0.11B $0.95B 10.84%
2011-09-30 $0.09B $1.02B 8.70%
2011-06-30 $0.09B $1.06B 8.64%
2011-03-31 $0.09B $1.03B 9.24%
2010-12-31 $0.09B $0.98B 9.48%
2010-09-30 $0.11B $1.00B 11.22%
2010-06-30 $0.11B $0.93B 11.45%
2010-03-31 $0.11B $0.93B 11.26%
2009-12-31 $0.10B $0.96B 10.57%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $14.725B $2.893B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.636B 20.70
Becton Dickinson (BDX) United States $65.447B 16.39
Cardinal Health (CAH) United States $30.771B 16.48
Straumann Holding AG (SAUHY) Switzerland $23.360B 0.00
Labcorp (LH) United States $20.840B 17.10
Cooper (COO) United States $17.701B 23.97
Align Technology (ALGN) United States $14.786B 28.09
Henry Schein (HSIC) United States $9.731B 18.54
Merit Medical Systems (MMSI) United States $6.158B 31.45
DENTSPLY SIRONA (XRAY) United States $3.767B 10.24
Patterson (PDCO) United States $2.743B 14.65
CONMED (CNMD) United States $1.895B 14.74
STAAR Surgical (STAA) United States $0.830B 0.00
Lifevantage (LFVN) United States $0.211B 23.31
Pro-Dex (PDEX) United States $0.109B 16.58